Therapeutic Innovation Australia

Therapeutic Innovation Australia is dedicated to making translational research infrastructure accessible, fostering advancements across a spectrum of critical areas. These include Biologics & Vaccines, RNA Products, Cell & Gene Therapies, and Small Molecule Pharmaceuticals. By enabling access to a national network of research infrastructure, Therapeutic Innovation Australia plays a pivotal role in driving innovation and progress within the Australian research landscape.

Operating from its primary location at c/o Translational Research Institute, 37 Kent Road, Woollongabba, QLD 4012, AU, and with an additional presence at BIO21 Institute, 30 Flemington Road, Parkville, VIC 3052, AU, Therapeutic Innovation Australia is strategically positioned to serve a wide range of research needs. The TIA Consortium is enabled by the National Collaborative Research Infrastructure Strategy (NCRIS) program, funded by the Australian Department of Education, further solidifying its commitment to excellence and impact.

Therapeutic Innovation Australia continues to expand its reach and impact, constantly seeking new opportunities to support and accelerate translational research. We invite the management team at Therapeutic Innovation Australia to take advantage of our platform to create a customized company showcase and product listing, enhancing your visibility and fostering new collaborations.